A detailed history of Hall Capital Management CO Inc transactions in Novartis Ag stock. As of the latest transaction made, Hall Capital Management CO Inc holds 5,178 shares of NVS stock, worth $560,414. This represents 0.25% of its overall portfolio holdings.

Number of Shares
5,178
Previous 5,032 2.9%
Holding current value
$560,414
Previous $508,000 1.57%
% of portfolio
0.25%
Previous 0.3%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$95.27 - $108.47 $13,909 - $15,836
146 Added 2.9%
5,178 $500,000
Q4 2023

Feb 13, 2024

SELL
$92.27 - $101.54 $7,658 - $8,427
-83 Reduced 1.62%
5,032 $508,000
Q3 2023

Oct 10, 2023

BUY
$94.73 - $105.13 $11,557 - $12,825
122 Added 2.44%
5,115 $521,000
Q2 2023

Aug 07, 2023

SELL
$92.52 - $104.91 $832 - $944
-9 Reduced 0.18%
4,993 $503,000
Q1 2023

Apr 17, 2023

BUY
$80.03 - $92.81 $9,203 - $10,673
115 Added 2.35%
5,002 $460,000
Q4 2022

Feb 10, 2023

SELL
$75.55 - $92.52 $102,899 - $126,012
-1,362 Reduced 21.8%
4,887 $443,000
Q3 2022

Oct 18, 2022

SELL
$74.61 - $87.26 $48,272 - $56,457
-647 Reduced 9.38%
6,249 $475,000
Q2 2022

Jul 19, 2022

SELL
$80.52 - $93.75 $23,350 - $27,187
-290 Reduced 4.04%
6,896 $583,000
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $20,027 - $22,655
-250 Reduced 3.36%
7,186 $631,000
Q4 2021

May 04, 2022

SELL
$79.7 - $88.13 $198,054 - $219,003
-2,485 Reduced 25.05%
7,436 $650,000
Q3 2021

Oct 08, 2021

BUY
$81.78 - $95.14 $26,006 - $30,254
318 Added 3.31%
9,921 $811,000
Q2 2021

Jul 14, 2021

SELL
$85.24 - $94.15 $234,410 - $258,912
-2,750 Reduced 22.26%
9,603 $876,000
Q4 2020

Mar 02, 2021

BUY
$78.07 - $94.43 $11,632 - $14,070
149 Added 1.22%
12,353 $1.17 Million
Q3 2020

Nov 12, 2020

BUY
$82.14 - $91.0 $45,751 - $50,687
557 Added 4.78%
12,204 $1.06 Million
Q2 2020

Nov 16, 2020

BUY
$80.93 - $91.1 $23,874 - $26,874
295 Added 2.6%
11,647 $1.02 Million
Q1 2020

Apr 29, 2020

SELL
$70.67 - $99.01 $25,441 - $35,643
-360 Reduced 3.07%
11,352 $936,000
Q4 2019

Feb 04, 2020

SELL
$84.35 - $95.37 $6,326 - $7,152
-75 Reduced 0.64%
11,712 $1.11 Million
Q3 2019

Oct 15, 2019

SELL
$85.54 - $94.26 $85,882 - $94,637
-1,004 Reduced 7.85%
11,787 $1.02 Million
Q2 2019

Aug 14, 2019

BUY
$75.4 - $92.8 $20,433 - $25,148
271 Added 2.16%
12,791 $1.17 Million
Q1 2019

May 06, 2019

SELL
$75.32 - $86.15 $18,830 - $21,537
-250 Reduced 1.96%
12,520 $1.2 Million
Q4 2018

Feb 14, 2019

BUY
$73.66 - $82.02 $5,524 - $6,151
75 Added 0.59%
12,770 $1.1 Million
Q3 2018

Nov 05, 2018

SELL
$66.94 - $77.43 $6,694 - $7,743
-100 Reduced 0.78%
12,695 $1.09 Million
Q2 2018

Aug 14, 2018

SELL
$64.91 - $73.36 $3,245 - $3,668
-50 Reduced 0.39%
12,795 $967,000
Q1 2018

May 15, 2018

SELL
$70.39 - $84.15 $25,340 - $30,294
-360 Reduced 2.73%
12,845 $1.04 Million
Q4 2017

Feb 02, 2018

BUY
$72.33 - $77.64 $18,444 - $19,798
255 Added 1.97%
13,205 $1.11 Million
Q3 2017

Oct 19, 2017

BUY
$74.14 - $77.27 $77,476 - $80,747
1,045 Added 8.78%
12,950 $1.11 Million
Q2 2017

Aug 14, 2017

BUY
N/A
11,905
11,905 $994,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $233B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Hall Capital Management CO Inc Portfolio

Follow Hall Capital Management CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hall Capital Management CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hall Capital Management CO Inc with notifications on news.